Lgt Group Foundation Merck & Co., Inc. Transaction History

Lgt Group Foundation

$4.3 Billion
Q1 2024

A detailed history of Lgt Group Foundation transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lgt Group Foundation holds 684,379 shares of MRK stock, worth $84.7 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares

684,379

Previous 692,516 1.17%

Holding current value

$84.7 Million

Previous $75.5 Million 19.61%

% of portfolio

2.1%

Previous 1.68%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $921,433 - $1.07 Million	-8,137 Reduced 1.17%	684,379 $90.3 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $1.32 Million - $1.44 Million	-13,191 Reduced 1.87%	692,516 $75.5 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $2.47 Million - $2.74 Million	23,964 Added 3.52%	705,707 $72.7 Million
Q2 2023 Jul 27, 2023	BUY	$108.61 - $118.38 $34.5 Million - $37.6 Million	318,015 Added 87.43%	681,743 $78.7 Million
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $316,540 - $353,194	3,075 Added 0.85%	363,728 $38.7 Million

Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $541,428 - $694,185	6,192 Added 1.75%	360,653 $40 Million
Q3 2022 Oct 19, 2022	BUY	$84.53 - $94.96 $4.9 Million - $5.5 Million	57,925 Added 19.53%	354,461 $30.5 Million
Q2 2022 Aug 03, 2022	BUY	$83.49 - $94.64 $9 Million - $10.2 Million	107,813 Added 57.13%	296,536 $27 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $3.83 Million - $4.3 Million	52,145 Added 38.18%	188,723 $15.8 Million
Q4 2021 May 03, 2022	BUY	$72.28 - $90.54 $9.87 Million - $12.4 Million	136,578 New	136,578 $10.5 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.

Account

Lgt Group Foundation Merck & Co., Inc. Transaction History